Eli Lilly says new GLP-1 weight loss pill could reach market in 2026
Eli Lilly is making progress on a new weight loss pill that uses the same GLP-1 technology as its popular injections, with plans to seek FDA approval by year-end and hopes of hitting the market by 2026.
RFK Jr. cancels $500 million in funding for vaccine development
Robert F. Kennedy Jr. has canceled $500 million in funding for vaccine development, specifically targeting mRNA vaccines, citing concerns over the technology's risks.
As measles vaccination rates fall and infections rise, scientists are developing drugs they say could prevent or treat the disease
Florida farm identified as source of raw milk that sickened 21
Why World Pulse Now?
Global Coverage
All major sources, one page
Emotional Lens
Feel the mood behind headlines
Trending Stories
Know what’s trending, globally
Read Less, Know More
Get summaries. Save time
Multi-Language
Switch languages to read your way
Save for Later
Your stories, stored for later
Live Stats
7,265
0
191
an hour ago
Mobile App
Available on iOS & AndroidThe mobile app adds more ways to stay informed — including offline reading, voice-enabled summaries, and personalized trend alerts.
1-Minute Daily Briefing
Stay sharp in 60 seconds. Get concise summaries of today’s biggest stories — markets, tech, sports, and more
Why World Pulse Now?
Global Coverage
All major sources, one page
Emotional Lens
Feel the mood behind headlines
Trending Stories
Know what’s trending, globally
Read Less, Know More
Get summaries. Save time
Multi-Language
Switch languages to read your way
Save for Later
Your stories, stored for later
Live Stats
7,265
0
191
an hour ago
Mobile App
Available on iOS & AndroidThe mobile app adds more ways to stay informed — including offline reading, voice-enabled summaries, and personalized trend alerts.
1-Minute Daily Briefing
Stay sharp in 60 seconds. Get concise summaries of today’s biggest stories — markets, tech, sports, and more